Fresenius Medical Care posted Q4 2024 revenue of €5.09 billion, reflecting a 2% year-over-year increase. Operating income fell 39% to €259 million due to portfolio optimization impacts, while net income dropped 64% to €67 million. The Care Enablement segment drove growth, increasing revenue by 11%, while Care Delivery revenue declined by 1% due to divestitures. Free cash flow improved by 25% to €599 million, supporting deleveraging efforts.
Total revenue grew 2% year-over-year to €5.09 billion, led by the Care Enablement segment.
Operating income declined 39% to €259 million due to one-time portfolio optimization effects.
Net income dropped 64% to €67 million, impacted by lower operating profit and restructuring costs.
Free cash flow increased by 25% to €599 million, supporting financial deleveraging efforts.
Fresenius Medical Care expects low single-digit revenue growth and high-teens to high-twenties percent earnings growth in 2025.
Visualization of income flow from segment revenue to net income